De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review

OBJECTIVE: Dual antiplatelet therapy (DAPT) with aspirin and a P2Y(12) receptor inhibitor is the cornerstone of treatment in patients with acute coronary syndromes (ACS) and in those undergoing percutaneous coronary intervention (PCI). In current clinical situation, availability of different oral P2...

Descripción completa

Detalles Bibliográficos
Autor principal: Han, Ya-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365275/
https://www.ncbi.nlm.nih.gov/pubmed/30614864
http://dx.doi.org/10.1097/CM9.0000000000000047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365275/
https://www.ncbi.nlm.nih.gov/pubmed/30614864
http://dx.doi.org/10.1097/CM9.0000000000000047

Ejemplares similares